Canaccord thinks the standalone value for Olink (OLK) is $13-$15 per share if the pending acquisition by Thermo Fisher (TMO) at $26 per share were blocked today. The merger is logical, but there remains regulatory events that create uncertainty, the analyst tells investors in a research note. The firm points out the acquisition is under investigation in the UK with a decision coming on July 8. Canaccord keeps a Hold rating on Olink with a $26 price target following the “relatively mixed” Q1 report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLK:
